2m 2m 2m 2m 2m 2m 2m
ABCELLERA BIOLOG (ABCL)
NASDAQ
$5.74+$0.004 (+0.07%)
Price as of Jun 23, 2026 6:36 PM EDT- $1.8BMarket Cap
- 72.37%1-Year Change
- BiotechnologyIndustry
ABCELLERA BIOLOG (ABCL)
$5.74+$0.004 (+0.07%)
ABCL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.74 | ||
Change | +$0.21 (+3.80%) | ||
Open | $5.58 | ||
High | $5.87 | ||
Low | $5.58 | ||
Previous Close | $5.53 | ||
Volume | 5,500,913 | ||
30-Day Average Volume | 6,527,706 | ||
1-Week Change | 9.13% | ||
1-Month Change | 10.38% | ||
1-Year Change | 72.37% | ||
3-Year Change | -20.28% | ||
5-Year Change | -73.99% | ||
Fundamentals | |||
Shares Outstanding | 305.4M | ||
Total Assets | $1.3B | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $8.1M | ||
Net Income | -$43.2M | ||
Free Cash Flow | -$37.4M | ||
EBIT | -$49.5M | ||
EBITDA | -$48.6M | ||
Net Working Capital | $617.3M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 214 | ||
P/B | 2 | ||
P/E | -41 | ||
PEG | 0 | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue